Steven N. Leff

Array ( [id] => 10784205 [patent_doc_number] => 20160130361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'ANTI-FACTOR VIII ANTIBODIES OR USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/894155 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29020 [patent_no_of_claims] => 138 [patent_no_of_ind_claims] => 71 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10966971 [patent_doc_number] => 20140370004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'METHOD OF BOOSTING THE IMMUNE RESPONSE IN NEONATES' [patent_app_type] => utility [patent_app_number] => 14/304803 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7437 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14304803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9950557 [patent_doc_number] => 08999339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Methods for treating chronic obstructive pulmonary disease' [patent_app_type] => utility [patent_app_number] => 14/298364 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7201 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11383180 [patent_doc_number] => 20170009236 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-01-12 [patent_title] => 'FUNCTIONAL LIGANDS TO TARGET MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/297484 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10901 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11383180 [patent_doc_number] => 20170009236 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-01-12 [patent_title] => 'FUNCTIONAL LIGANDS TO TARGET MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/297484 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10901 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720255 [patent_doc_number] => 20140255956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'DIAGNOSIS OF MYOCARDIAL AUTOIMMUNITY IN HEART DISEASE' [patent_app_type] => utility [patent_app_number] => 14/288269 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7284 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14288269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14639111 [patent_doc_number] => 10364288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-30 [patent_title] => Anti-GPIIB/IIIA antibodies or uses thereof [patent_app_type] => utility [patent_app_number] => 14/890653 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 45339 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225799 [patent_doc_number] => 20150110791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/283038 [patent_app_country] => US [patent_app_date] => 2014-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 57147 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14283038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11082287 [patent_doc_number] => 20160279252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTOR PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/787444 [patent_app_country] => US [patent_app_date] => 2014-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29058 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10714176 [patent_doc_number] => 20160060324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'Methods and Compositions for Treating Bleeding Disorders' [patent_app_type] => utility [patent_app_number] => 14/786419 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13690 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641931 [patent_doc_number] => 20140220042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'ANTI-C (EPSILON)MX ANTIBODIES CAPABLE OF BINDING TO HUMAN MIGE ON B LYMPHOCYTES' [patent_app_type] => utility [patent_app_number] => 14/254453 [patent_app_country] => US [patent_app_date] => 2014-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4852 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641903 [patent_doc_number] => 20140220015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 14/253432 [patent_app_country] => US [patent_app_date] => 2014-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14253432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11549681 [patent_doc_number] => 09618521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Sperm-specific cation channel, Catsper2, and uses therefor' [patent_app_type] => utility [patent_app_number] => 14/249990 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24062 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874727 [patent_doc_number] => 08961992 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-02-24 [patent_title] => 'Epsigam fusion protein' [patent_app_type] => utility [patent_app_number] => 14/243750 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8231 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14243750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919199 [patent_doc_number] => 20140322219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/242692 [patent_app_country] => US [patent_app_date] => 2014-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28735 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14242692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670441 [patent_doc_number] => 20140234304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'HUMAN TISSUE FACTOR ANTIBODY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/230128 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21728 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14230128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785225 [patent_doc_number] => 20140302045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'IGY COMPOSITION FOR USE IN CELIAC DISEASE' [patent_app_type] => utility [patent_app_number] => 14/225882 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5822 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10233264 [patent_doc_number] => 20150118256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'IGE CH3 Peptide Vaccine' [patent_app_type] => utility [patent_app_number] => 14/225258 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 48648 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864222 [patent_doc_number] => 20150044241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'CONTRACEPTIVE VACCINES FOR MAMMALS' [patent_app_type] => utility [patent_app_number] => 14/221980 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3358 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692430 [patent_doc_number] => 20160038575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE INDUCTION TO FACTOR VIII REPLACEMENT THERAPIES IN SUBJECTS WITH HEMOPHILIA A' [patent_app_type] => utility [patent_app_number] => 14/776709 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 41015 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776709 [rel_patent_id] =>[rel_patent_doc_number] =>)